Holen Sie sich die Stockscreener-App
7.08
8.83%
0.5744
Schlusskurs vom Vortag:
$6.5056
Offen:
$6.38
24-Stunden-Volumen:
1,511
Relative Volume:
0.28
Marktkapitalisierung:
$46.10M
Einnahmen:
Nettoeinkommen (Verlust:
$-26.28M
KGV:
-1.6507
EPS:
-4.2891
Netto-Cashflow:
$-12.39M
1W Leistung:
+0.28%
1M Leistung:
-8.65%
6M Leistung:
+9.94%
1J Leistung:
-81.24%
1-Tages-Spanne:
$6.38
$7.09
1-Wochen-Bereich:
$6.38
$7.15
52-Wochen-Spanne:
$3.6364
$39.00
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Firmenname
Tevogen Bio Holdings Inc
Sektor
Branche
Telefon
646-807-8832
Adresse
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
7.08 | 46.10M | 0 | -26.28M | -12.39M | -4.2891 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-04 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-03-04 | Eingeleitet | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
Nasdaq issues a decision on the $50M listing requirement for Tevogen (NASDAQ: TVGN). - Stock Titan
Tevogen Bio grants major performance-based executive stock awards - TipRanks
A $1 billion sales goal now decides whether a Tevogen Inc. (TVGN) insider keeps 750K shares - Stock Titan
8M-share grant at Tevogen (TVGN) tied to $1B revenue goal - Stock Titan
Tevogen (TVGN) CEO faces $1B revenue hurdle for performance stock - Stock Titan
Tevogen (TVGN) ties CFO stock grant to $1B revenue goal - Stock Titan
Tevogen (Nasdaq: TVGN) conditions CEO's 8M-share award on a $1 billion revenue hurdle - Stock Titan
PODLOGAR SUSAN M Awarded 75,000 Shares of Tevogen Inc. in Director Grant - Kalkine Media
Patton Curtis L. Awarded 75,000 Shares of Tevogen Inc., Increasing Holdings to 139,192 Shares - Kalkine Media
Tevogen Inc. (NASDAQ: TVGN) awards 75,000-share stock grant to director - Stock Titan
Form 8K Tevogen Bio Holdings Inc For: 10 September By Investing.com - Investing.com Nigeria
Form 8K Tevogen Bio Holdings Inc For: 10 September By Investing.com - Investing.com Canada
Tevogen regains Nasdaq compliance with minimum market value requirement - Investing.com
Form 8K Tevogen Bio Holdings Inc For: 10 September By Investing.com - Investing.com India
Tevogen regains Nasdaq compliance with minimum market value requirement By Investing.com - Investing.com UK
Tevogen Bio regains Nasdaq listing compliance status - TipRanks
Tevogen (Nasdaq: TVGN) back in line with $15M Nasdaq rule - Stock Titan
Tevogen Bio Holdings (TVGN) Holds Near $7 as Biotech Stock Consolidates Between Support and ResistanceFundamental Weighted - dars.gov.et
Tevogen Bio Holdings (TVGN) Holds Near $7 as Biotech Stock Consolidates Between Support and ResistanceBuffered ETF - dars.gov.et
Tevogen Bio (TVGN) Rises to $6.98 as Resistance at $7.33 Comes Into FocusExhaustion Gap - vinanet.vn
Tevogen (TVGN) adds 100M to equity plan, OKs written consent - Stock Titan
Tevogen Bio Holdings (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss Drives 4.57% Share GainSubscription Growth Report - vinanet.vn
Tevogen Bio Holdings (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss Drives 4.57% Share GainEPS Estimate Trend - dars.gov.et
TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss Signals Improved Cost Discipline for Clinical-Stage Biotech - vinanet.vn
Tevogen Inc (TVGN) narrows first-half loss amid tight cash and heavy R&D - Stock Titan
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) Share Price, TVGN Stock News, TVGN Share Price & Updates - Kalkine
TVGN Q4 2025 Earnings: Narrower-than-Expected Loss Highlights Pre-Revenue StageEPS Consistency Score - vinanet.vn
TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline at Pre-Revenue BiotechMargin Expansion Trends - vinanet.vn
Tevogen Bio Holdings Inc (TVGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form DEF 14A Tevogen Inc. For: 3 August By Investing.com - Investing.com Canada
Tevogen Inc. (NASDAQ: TVGN) targets huge 2024 equity pool expansion - Stock Titan
Tevogen Bio (TVGN) Holds Near $7.02 as Biotech Stock Navigates Tight Trading RangeCall Resistance - vinanet.vn
Tevogen Bio (TVGN) Advances 4.9% to $7.05, Edging Toward Key Resistance at $7.40Statistical Arbitrage - vinanet.vn
Tevogen Bio Q4 2025 Earnings: Narrower-Than-Expected Loss Lifts Shares 4.91%Earnings Volatility Report - vinanet.vn
Tevogen Bio Holdings Rebrands as Tevogen Inc. - theglobeandmail.com
Tevogen Bio Holdings Rebrands as Tevogen Inc. - TipRanks
Tevogen Inc. (NASDAQ: TVGN) changes name from Tevogen Bio Holdings - Stock Titan
Tevogen Bio Holdings Inc. Becomes Tevogen Inc. - GlobeNewswire
Tevogen will use new name July 30; TVGN and TVGNW stay - Stock Titan
Tevogen Bio Holdings Inc. Becomes Tevogen Inc. - Yahoo Finance
Tevogen Bio Holdings Inc (TVGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tevogen Bio Holdings Market Sentiment - Benzinga
Tevogen Bio Holdings Inc (TVGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tevogen Bio Holdings Inc (TVGN) Income Statement - TradingKey
Tevogen Bio Holdings Inc (TVGN) Balance Sheet - TradingKey
Tevogen Bio Holdings Inc (TVGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TVGN|Tevogen Bio Holdings Inc|Price:5.410|Chg%:+0.920 - TradingKey
Tevogen Bio Holdings Inc (TVGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TVGN|Tevogen Bio Holdings Inc|Price:5.410|Chg%:+0.920 - TradingKey
TradingKey - TradingKey
Finanzdaten der Tevogen Bio Holdings Inc-Aktie (TVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tevogen Bio Holdings Inc-Aktie (TVGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Flomenberg Neal | See Remarks |
Mar 13 '26 |
Sale |
6.40 |
501 |
3,206 |
76,940 |
| Flomenberg Neal | See Remarks |
Mar 10 '26 |
Sale |
7.75 |
19 |
147 |
77,893 |
| Desai Kirti | Officer |
Feb 06 '26 |
Proposed Sale |
0.31 |
330,000 |
103,224 |
0 |
| Desai Kirti | Officer |
Dec 30 '25 |
Proposed Sale |
0.40 |
15,500 |
6,149 |
0 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):